Log In
Print
BCIQ
Print
Print this Print this
 

Casodex, bicalutamide

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionOral non-steroidal androgen receptor inhibitor
Molecular Target Androgen receptor
Mechanism of ActionAndrogen receptor antagonist
Latest Stage of DevelopmentMarketed
IndicationProstate cancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today